X-129919275-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_ModerateBP6_ModerateBS2
The ENST00000394422.8(UTP14A):c.638G>A(p.Arg213Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000587 in 1,209,716 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 21 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
ENST00000394422.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UTP14A | NM_006649.4 | c.638G>A | p.Arg213Gln | missense_variant | 7/15 | ENST00000394422.8 | NP_006640.2 | |
LOC105373335 | XR_007068332.1 | n.1774-10332C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UTP14A | ENST00000394422.8 | c.638G>A | p.Arg213Gln | missense_variant | 7/15 | 1 | NM_006649.4 | ENSP00000377944 | P1 | |
ENST00000432062.1 | n.206+10483C>T | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000449 AC: 5AN: 111476Hom.: 0 Cov.: 23 AF XY: 0.0000297 AC XY: 1AN XY: 33684
GnomAD3 exomes AF: 0.0000327 AC: 6AN: 183451Hom.: 0 AF XY: 0.0000295 AC XY: 2AN XY: 67885
GnomAD4 exome AF: 0.0000601 AC: 66AN: 1098240Hom.: 0 Cov.: 31 AF XY: 0.0000550 AC XY: 20AN XY: 363596
GnomAD4 genome AF: 0.0000449 AC: 5AN: 111476Hom.: 0 Cov.: 23 AF XY: 0.0000297 AC XY: 1AN XY: 33684
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 22, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at